Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc

ABSTRACT: The aim of this study is to evaluate the efficacy of the effective drugs in a alternating chemotherapy schedules in pretreated patients with mCRC, who have received all effective drugs.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2061238 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR